These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3087760)

  • 1. The effect of selective noradrenergic lesions upon the stimulation by noradrenaline of inositol phospholipid breakdown in rat hippocampal miniprisms.
    Fowler CJ; Magnusson O; Mohammed AK; Danysz W; Archer T
    Eur J Pharmacol; 1986 Apr; 123(3):401-7. PubMed ID: 3087760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-adrenoceptor function in the rat hippocampus as assessed by noradrenaline-stimulated inositol phospholipid breakdown after destruction of noradrenergic neurons by neonatal 6-hydroxydopamine treatment.
    Fowler CJ; Fagervall I; Minor BG; Ross SB
    J Pharm Pharmacol; 1986 May; 38(5):385-8. PubMed ID: 2872317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: relationship between receptor occupancy and response and effects of denervation.
    Kendall DA; Brown E; Nahorski SR
    Eur J Pharmacol; 1985 Aug; 114(1):41-52. PubMed ID: 2995075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of inositol phospholipid breakdown in rat cortical and hippocampal miniprisms by noradrenaline, 5-hydroxytryptamine and carbachol: some methodological aspects.
    Fowler CJ; Court JA; Tiger G; Björklund PE; Candy JM
    Pharmacol Toxicol; 1987 Apr; 60(4):274-9. PubMed ID: 3588525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenaline-stimulated inositol phospholipid breakdown as a measure of alpha 1-adrenoceptor function in rat hippocampal miniprisms after repeated antidepressant treatment.
    Fowler CJ; Danysz W; Archer T
    J Neural Transm; 1986; 66(3-4):197-208. PubMed ID: 3023545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine-stimulated inositol phospholipid breakdown in the rat cerebral cortex following serotoninergic lesion.
    Fowler CJ; Thorell G; Sundström E; Archer T
    J Neural Transm; 1988; 73(3):205-15. PubMed ID: 2850349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenaline-stimulated inositol phospholipid breakdown in rat dorsal lateral geniculate nucleus neurones.
    Kemp JA; Downes CP
    Brain Res; 1986 Apr; 371(2):314-8. PubMed ID: 3008945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute effects of 6-hydroxydopamine treatment on noradrenergic function in the rat hippocampus in vitro.
    Yasuda RP; Dunwiddie TV; Zahniser NR
    Brain Res; 1986 Mar; 367(1-2):121-7. PubMed ID: 3008918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of dorsal bundle lesions in rats to increase distractibility to a low intensity tone.
    Dragunow M; Laverty R
    Pharmacol Biochem Behav; 1983 May; 18(5):673-5. PubMed ID: 6407033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of selective noradrenergic denervation on thyrotropin secretion in the rat.
    Jaffer A; Searson A; Russell VA; Taljaard JJ
    Neurochem Res; 1990 Jan; 15(1):13-6. PubMed ID: 2325821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into the effects in-vitro of the 5-hydroxytryptamine reuptake inhibitor, alaproclate, on carbachol-stimulated inositol phospholipid breakdown in the rat cerebral cortex.
    Fowler CJ; Thorell G; Ogren SO
    J Pharm Pharmacol; 1987 Dec; 39(12):1015-8. PubMed ID: 2894427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
    Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of spinal norepinephrine depletion on descending inhibition of the tail flick reflex from the locus coeruleus and lateral reticular nucleus in the rat.
    Janss AJ; Jones SL; Gebhart GF
    Brain Res; 1987 Jan; 400(1):40-52. PubMed ID: 3101973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible involvement of changes in phosphoinositol turnover in the responses of renal sodium transport to noradrenaline.
    Plevin RJ; Parsons BJ; Butcher P; Poat JA
    Biochem Pharmacol; 1988 Jun; 37(11):2121-4. PubMed ID: 2837226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation by noradrenaline of inositol phospholipid breakdown in the rat hippocampus: effect of the ambient potassium concentration.
    Fowler CJ; O'Carroll AM; Court JA; Candy JM
    J Pharm Pharmacol; 1986 Mar; 38(3):201-8. PubMed ID: 2871155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic denervation increases alpha 1-adrenoceptor-mediated inositol-phosphate accumulation in the hippocampus.
    Janowsky A; Labarca R; Paul SM
    Eur J Pharmacol; 1984 Jun; 102(1):193-4. PubMed ID: 6090158
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonist effects of the enantiomers of 3-PPP towards alpha 1-adrenoceptors coupled to inositol phospholipid breakdown in the rat cerebral cortex.
    Fowler CJ; Thorell G
    Pharmacol Toxicol; 1987 May; 60(5):389-92. PubMed ID: 3039482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic noradrenergic regulation of neurotrophin messenger RNA expression in rat hippocampus: evidence from lesions and organotypic cultures.
    Hutter P; Johansson M; Saria A; Humpel C
    Neuroscience; 1996 Jan; 70(1):15-29. PubMed ID: 8848120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the locus coeruleus involvement in desipramine action in animal models of depression.
    Danysz W; Kostowski W; Hauptmann M
    Pol J Pharmacol Pharm; 1985; 37(6):855-64. PubMed ID: 3938536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.